On January 7, the Food and Drug Administration (FDA) approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. Read…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.